Created:   11/14/2016
Contains:  34 items

1 2 3 4 5

Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After...

Zittan, Eran; Milgrom, Raquel; Ma, Grace W.; More

Inflammatory Bowel Diseases. 22(10):2442-2447, October 2016.

Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease

Conrad, Máire A.; Stein, Ronen E.; Maxwell, Elizabeth C.; More

Inflammatory Bowel Diseases. 22(10):2425-2431, October 2016.

Looking Beyond Mucosal Healing: Effect of Biologic Therapy on Transmural Healing in Pediatric Crohn's Disease

Civitelli, Fortunata; Nuti, Federica; Oliva, Salvatore; More

Inflammatory Bowel Diseases. 22(10):2418-2424, October 2016.

Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease

Levy, Rona L.; van Tilburg, Miranda A. L.; Langer, Shelby L.; More

Inflammatory Bowel Diseases. 22(9):2134-2148, September 2016.

Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis

Aloi, Marina; D'Arcangelo, Giulia; Bramuzzo, Matteo; More

Inflammatory Bowel Diseases. 22(7):1647-1654, July 2016.

Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study

Nguyen, Geoffrey C.; Croitoru, Ken; Silverberg, Mark S.; More

Inflammatory Bowel Diseases. 22(6):1412-1417, June 2016.

Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

Dubinsky, Marla C.; Rosh, Joel; Faubion, William A. Jr; More

Inflammatory Bowel Diseases. 22(4):886-893, April 2016.

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

Guerra, Iván; Pérez-Jeldres, Tamara; Iborra, Marisa; More

Inflammatory Bowel Diseases. 22(4):894-901, April 2016.

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy

Poullenot, Florian; Seksik, Philippe; Beaugerie, Laurent; More

Inflammatory Bowel Diseases. 22(6):1362-1369, June 2016.

  • Press Release

Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study

Prosberg, Michelle V.; Vester-Andersen, Marianne K.; Andersson, Mikael; More

Inflammatory Bowel Diseases. 22(4):925-932, April 2016.

Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study

Ma, Christopher; Beilman, Candace L.; Huang, Vivian W.; More

Inflammatory Bowel Diseases. 22(4):870-879, April 2016.

Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial

deBruyn, Jennifer; Fonseca, Kevin; Ghosh, Subrata; More

Inflammatory Bowel Diseases. 22(3):638-647, March 2016.

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort

Shelton, Edward; Allegretti, Jessica R.; Stevens, Betsy; More

Inflammatory Bowel Diseases. 21(12):2879-2885, December 2015.

Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977–2011

Trier Moller, Frederik; Andersen, Vibeke; Andersson, Mikael; More

Inflammatory Bowel Diseases. 21(12):2825-2832, December 2015.

Anti–Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper

Holubar, Stefan D.; Holder-Murray, Jennifer; Flasar, Mark; More

Inflammatory Bowel Diseases. 21(11):2658-2672, November 2015.

Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response...

Suzuki, Yasuo; Matsui, Toshiyuki; Ito, Hiroaki; More

Inflammatory Bowel Diseases. 21(9):2114-2122, September 2015.

Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease

Lee, Dale; Baldassano, Robert N.; Otley, Anthony R.; More

Inflammatory Bowel Diseases. 21(8):1786-1793, August 2015.

Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD: Evolution in the Definition and Management of Primary Nonresponse

Papamichael, Konstantinos; Gils, Ann; Rutgeerts, Paul; More

Inflammatory Bowel Diseases. 21(1):182-197, January 2015.

Influence of Combination Therapy with Immune Modulators on Anti-TNF Trough Levels and Antibodies in Patients with IBD

van Schaik, Tamara; Maljaars, Jeroen P. W.; Roopram, Rajiv K.; More

Inflammatory Bowel Diseases. 20(12):2292-2298, December 2014.

1 2 3 4 5